表紙
市場調査レポート

中国における豚繁殖・呼吸障害症候群(PRRS)ワクチン産業の分析

Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2014-2018

発行 China Research and Intelligence 商品コード 288686
出版日 ページ情報 英文 50 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
中国における豚繁殖・呼吸障害症候群(PRRS)ワクチン産業の分析 Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2014-2018
出版日: 2014年09月17日 ページ情報: 英文 50 Pages
概要

中国は、世界最大の豚肉の生産国・消費国で、その生産量は全体のほぼ50%を占めています。豚繁殖・呼吸障害症候群(PRRS)は、中国南部で発生し、2006年夏以降に全国に急速に広がりました。現在、高病原性PRRSワクチンが、中国政府によって購入されています。

当レポートでは、中国のPRRSワクチン産業について調査分析し、市場の状況、発展への影響要因、運営状況、主要メーカーなどについて、体系的な情報を提供しています。

第1章 世界と中国のPRRSワクチン市場の状況

  • PRRSワクチンの関連概念
    • PRRSの定義
    • PRRSワクチンの定義
  • PRRSの流行状況の概要
    • PRRSの流行状況
    • 中国のPRRSの流行状況

第2章 中国におけるPRRSワクチンの発展への影響要因

  • 中国の動物ワクチン産業の政策
    • 動物防疫に関する法律
    • 組織構造
    • 防疫の割当予算
    • 強制予防接種の範囲
    • PRRSの予防接種
  • 中国における養豚の概要
    • 豚の家畜頭数
    • 肥育豚の家畜頭数
    • 豚肉の生産量

第3章 中国のPRRSワクチン産業の運営状況

  • PRRSワクチンの供給
    • 供給概要
    • 供給への影響要因
  • 需要
    • 需要概要
    • 需要への影響要因
  • 政府によって無償で提供されるPRRSワクチンの状況
    • 既存の問題の分析
    • 問題への解決策

第4章 中国におけるPRRSワクチンの主要メーカー

  • 企業プロファイル、生産状況、開発戦略
    • Guangdong Dahuanong Animal Health Products Co., Ltd.
    • Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd.
    • Qingdao Yebio Bioengineering Co., Ltd.
    • Inner Mongolia Jinyu Group Stock Company

第5章 中国における一部の地方自治体によるPRRSワクチン購入の状況

  • 山東省におけるPRRSワクチンの落札状況
  • 山西省におけるPRRSワクチンの落札状況

第6章 中国におけるPRRSワクチン産業の見通し

  • 発展への影響要因
  • 需給予測

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 1409177

China is the world's largest producer and consumer of pork with the output volume of pork accounting for nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.

The PRRS broke out in southern China and spread rapidly nationwide after summer in 2006, which lead to increases in mortality rate of piglets and pork prices and significant decrease in output volume of pork. In May 2007, the Ministry of Agriculture of China approved the production of highly-pathogenic porcine reproductive and respiratory syndrome inactivated vaccine (NVDC-JXA1) in six manufacturers of biological products. Porcine reproductive and respiratory syndrome (PRRS) remains one of the key compulsory immunity diseases in China.

According to National Compulsory Immunization Plan of Animal Epidemic Diseases in 2014 issued by Ministry of Agriculture of China, the government conducts compulsory immunizations against 4 diseases, including highly-pathogenic PRRS. The government is responsible for the expenses. Currently highly pathogenic PRRS vaccines are purchased by the government through invitation for bidding in China.

The market competition is intensive in the PRRS vaccine industry in China. There are 26 manufacturers of PRRS vaccines in China, including Dahuanong, Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd., Qingdao Yebio Bioengineering Co., Ltd. and Inner Mongolia Jinyu Group Stock Company. In terms of the direct sales of high-end vaccines, the PRRS vaccines of Zoetis went to the market in Guangzhou at the end of August 2013 after Boehringer. These foreign-funded vaccine brands occupy the market shares using the brand advantages, which intensify the market competition.

As Chinese economy develops and the living standards increase, the demand for pork will continue to grow, which promotes the development of pig raising industry. The market size of PRRS vaccines will continue to increase in China in the next few years, which attract many animal health enterprises' attention.

Through this report, the readers can acquire the following information:

  • Incidence Status of Porcine Reproductive and Respiratory Syndrome
  • Status of China Breeding Industry
  • Policy Environment and Government Procurement of PRRS Vaccines in China
  • Supply and Demand Status of PRRS Vaccines in China
  • Major Manufacturers of PRRS Vaccines and the Operation Status in China
  • Prospect of China PRRS Vaccine Industry in China

The Following Enterprises and People Are Recommended to Purchase This Report:

  • Manufacturers and Trading Enterprises of Animal Vaccines
  • Breeding Enterprises
  • Management Organizations of Livestock Industry
  • Investors and Research Institutes Concerned about PRRS Vaccine Industry

Table of Contents

1. Status of Global and China PRRS Vaccine Market

  • 1.1. Relevant Concepts of PRRS Vaccines
    • 1.1.1. Definition of PRRS
    • 1.1.2. Definition of PRRS Vaccine
  • 1.2. Brief Introduction of Epidemic Situation of PRRS
    • 1.2.1. Incidence Status of PRRS
    • 1.2.2. Epidemic Situation of PRRS in China

2. Factors Influencing Development of PRRS Vaccines in China, 2009-2013

  • 2.1. Policies in China Animal Vaccine Industry
    • 2.1.1. Legislation of Animal Epidemic Prevention
    • 2.1.2. Organization Structure
    • 2.1.3. Appropriation Budget of Epidemic Prevention
    • 2.1.4. Scope of Compulsory Immunization
    • 2.1.5. Immunization Policies on Highly-pathogenic PRRS
  • 2.2. Overview of Pig Breeding in China, 2009-2013
    • 2.2.1. Livestock Volume of Pigs
    • 2.2.2. Stock Volume of Fattened Pigs
    • 2.2.3. Output Volume of Pork

3. Operation Status of PRRS Vaccine Industry in China, 2009-2013

  • 3.1. Supply of PRRS Vaccines
    • 3.1.1. Supply Overview
    • 3.1.2. Factors Influencing Supply
  • 3.2. Demand
    • 3.2.1. Demand Overview
    • 3.2.2. Factors Influencing Demand
  • 3.3. Status of Free PRRS Vaccines Provided by the Government
    • 3.3.1. Analysis of Existing Problems
    • 3.3.2. Solutions to Problems

4. Major Manufacturers of PRRS Vaccines in China, 2011-2013

  • 4.1. Guangdong Dahuanong Animal Health Products Co., Ltd.
    • 4.1.1. Enterprise Profile
    • 4.1.2. Production Status of PRRS Vaccines
    • 4.1.3. Development Strategies of the Enterprise
  • 4.2. Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd.
    • 4.2.1. Enterprise Profile
    • 4.2.2. Production Status of PRRS Vaccines
    • 4.2.3. Development Strategies
  • 4.3. Qingdao Yebio Bioengineering Co., Ltd.
    • 4.3.1. Enterprise Profile
    • 4.3.2. Production Status of PRRS Vaccines
    • 4.3.3. Development Strategies
  • 4.4. Inner Mongolia Jinyu Group Stock Company
    • 4.4.1. Enterprise Profile
    • 4.4.2. Production Status of PRRS Vaccines
    • 4.4.3. Development Strategies

5. Status of PRRS Vaccine Purchase in Some Local Governments in China, 2013

  • 5.1. Bid Winning Status of PRRS Vaccines in Shandong, 2013
    • 5.1.1. Bid Winning Enterprises and Products of PRRS Vaccines
    • 5.1.2. Bid Winning Prices
  • 5.2. Bid Winning Status of PRRS Vaccines in Shanxi, 2013
    • 5.2.1. Bid Winning Enterprises and Products of PRRS Vaccines
    • 5.2.2. Bid Winning Prices

6. Prospect of China PRRS Vaccine Industry, 2014-2018

  • 6.1. Factors Influencing Development
    • 6.1.1. Government Policies
    • 6.1.2. Pig Breeding
  • 6.2. Forecast on Supply and Demand
    • 6.2.1. Forecast on Supply of PRRS Vaccines
    • 6.2.2. Forecast on Demand for PRRS Vaccines

Selected Charts

  • Chart Epidemic Situation of PRRS in China, 2012-2014
  • Chart Expenses of Chinese Government on Animal Epidemic Prevention, 2009-2014
  • Chart Stock Volume of Fattened Pigs in China, 2009-2013
  • Chart Output Volume of Pork in China, 2009-2013
  • Chart Major Types of PRRS Vaccines in China
  • Chart Market Size of PRRS Vaccines in China, 2009-2013
  • Chart Forecast on Output Volume of PRRS Vaccines in China, 2014-2018
  • Chart Forecast on Market Size of PRRS Vaccines in China, 2014-2018
Back to Top